- Published at
- by seekingalpha.com
neutral
neutral
Lantern Pharma outlines 2025 clinical milestones and key updates on oncology trials (NASDAQ:LTRN)
Discover Lantern Pharma's transformative 2024 journey in precision oncology with AI breakthroughs, global trial expansions, and key clinical milestones for...